283 related articles for article (PubMed ID: 11769768)
1. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
Harries AD; Hargreaves NJ; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
[TBL] [Abstract][Full Text] [Related]
2. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.
Harries AD; Zachariah R; Lawn SD
Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
Nuwaha F
East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
[TBL] [Abstract][Full Text] [Related]
6. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
Nuwaha F
East Afr Med J; 1998 Jun; 75(6):358-63. PubMed ID: 9803621
[TBL] [Abstract][Full Text] [Related]
7. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
Maher D; Harries A; Getahun H
Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
11. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
Harries AD; Maher D; Nunn P
Bull World Health Organ; 1997; 75(5):477-89. PubMed ID: 9447782
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
13. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
14. TB control programmes: the challenges for Africa.
Harries T
Afr Health; 1996 Nov; 19(1):19-20. PubMed ID: 12291916
[TBL] [Abstract][Full Text] [Related]
15. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes?
Harries AD; Chimzizi RB; Nyirenda TE; van Gorkom J; Salaniponi FM
Int J Tuberc Lung Dis; 2003 Jul; 7(7):616-22. PubMed ID: 12870681
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand.
Punnotok J; Shaffer N; Naiwatanakul T; Pumprueg U; Subhannachart P; Ittiravivongs A; Chuchotthaworn C; Ponglertnapagorn P; Chantharojwong N; Young NL; Limpakarnjanarat K; Mastro TD
Int J Tuberc Lung Dis; 2000 Jun; 4(6):537-43. PubMed ID: 10864184
[TBL] [Abstract][Full Text] [Related]
17. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
Habib AG
Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
[TBL] [Abstract][Full Text] [Related]
18. Thai drug-resistant tuberculosis predictive scores.
Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
[TBL] [Abstract][Full Text] [Related]
19. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.
Harries AD; Maher D; Nunn P
Bull World Health Organ; 1998; 76(6):651-62. PubMed ID: 10191561
[TBL] [Abstract][Full Text] [Related]
20. Association between HIV and tuberculosis: technical guide.
Bull Pan Am Health Organ; 1993; 27(3):297-310. PubMed ID: 8220525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]